Cargando…

DNA Vaccines against Protozoan Parasites: Advances and Challenges

Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of the advances and challenges for the development o...

Descripción completa

Detalles Bibliográficos
Autor principal: Dumonteil, Eric
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940056/
https://www.ncbi.nlm.nih.gov/pubmed/17710244
http://dx.doi.org/10.1155/2007/90520
_version_ 1782134435042295808
author Dumonteil, Eric
author_facet Dumonteil, Eric
author_sort Dumonteil, Eric
collection PubMed
description Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of the advances and challenges for the development of DNA vaccines against these diseases. Many studies have validated the concept of using DNA vaccines for both protection and therapy against these protozoan parasites in a variety of mouse models. The challenge now is to translate what has been achieved in these models into veterinary or human vaccines of comparable efficacy. Also, genome-mining and new antigen discovery strategies may provide new tools for a more rational search of novel vaccine candidates.
format Text
id pubmed-1940056
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-19400562007-08-20 DNA Vaccines against Protozoan Parasites: Advances and Challenges Dumonteil, Eric J Biomed Biotechnol Review Article Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of the advances and challenges for the development of DNA vaccines against these diseases. Many studies have validated the concept of using DNA vaccines for both protection and therapy against these protozoan parasites in a variety of mouse models. The challenge now is to translate what has been achieved in these models into veterinary or human vaccines of comparable efficacy. Also, genome-mining and new antigen discovery strategies may provide new tools for a more rational search of novel vaccine candidates. Hindawi Publishing Corporation 2007 2007-06-24 /pmc/articles/PMC1940056/ /pubmed/17710244 http://dx.doi.org/10.1155/2007/90520 Text en Copyright © 2007 Eric Dumonteil. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Dumonteil, Eric
DNA Vaccines against Protozoan Parasites: Advances and Challenges
title DNA Vaccines against Protozoan Parasites: Advances and Challenges
title_full DNA Vaccines against Protozoan Parasites: Advances and Challenges
title_fullStr DNA Vaccines against Protozoan Parasites: Advances and Challenges
title_full_unstemmed DNA Vaccines against Protozoan Parasites: Advances and Challenges
title_short DNA Vaccines against Protozoan Parasites: Advances and Challenges
title_sort dna vaccines against protozoan parasites: advances and challenges
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940056/
https://www.ncbi.nlm.nih.gov/pubmed/17710244
http://dx.doi.org/10.1155/2007/90520
work_keys_str_mv AT dumonteileric dnavaccinesagainstprotozoanparasitesadvancesandchallenges